Nathan Stasko Selected Research

berdazimer sodium

10/2018	A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment.
1/2018	Nitric Oxide-Releasing Macromolecule Exhibits Broad-Spectrum Antifungal Activity and Utility as a Topical Treatment for Superficial Fungal Infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathan Stasko Research Topics

Disease

4	COVID-19 01/2022 - 01/2022
1	Infections 01/2022
1	Skin Diseases (Skin Disease) 10/2018
1	Warts (Wart) 10/2018
1	Tinea Pedis (Athlete's Foot) 08/2018
1	Onychomycosis (Tinea Unguium) 01/2018
1	Mycoses (Diseases, Fungus) 01/2018
1	Acne Vulgaris 08/2016

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 10/2018 - 08/2016
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2018 - 08/2016
2	berdazimer sodiumIBA 10/2018 - 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	AntigensIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Artificial SalivaIBA 01/2022
1	VaccinesIBA 01/2022
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 10/2018
1	Investigational DrugsIBA 10/2018
1	HydrogelsIBA 10/2018
1	Siloxanes (Siloxane)IBA 01/2018

Therapy/Procedure

1	Phototherapy (Light Therapy) 01/2022
1	Therapeutics 01/2018